Axess Vision Technology

company

About

Axess Vision Technology specializes in the design of sterile endoscopes for single use.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
€3.50M
Industries
Health Care,Medical Device
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Active

Axess Vision Technology specializes in the design of sterile endoscopes for single use.

The health sector is changing. The regulations are tightening , new diseases are emerging more and more resistant .

Patient safety , in this context, is a priority.

Axess Vision has set a mission to provide safety and comfort for patients, while improving and facilitating the work of practitioners . To succeed, our watchword is “innovation” . Innovation as a growth engine .

With only 10 years of existence, Axess Vision Technology has combined R&D and commercial launch of products.

After eight years of R & D, we now offer new solutions in the field of endoscopy . Solutions developed with the assistance of a panel of medical experts. Since 2014, the first single use endoscope is for sale. In April 2016, a new endoscope has been launched on the market, followed by two new visualization systems replacing the old.

Rich of these years of work, the company also claims its social and societal responsibility through a commitment to sustainable development, and its involvement in the local economy.

Employees Axess Vision raised incredible challenges , file 7 patents and continue constantly innovating.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3.50M
Axess Vision Technology has raised a total of €3.50M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2013 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2013 Series B €3.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Axess Vision Technology is funded by 1 investors. Apicap are the most recent investors.
Investor Name Lead Investor Funding Round
Apicap Series B